Table 1. Patients' characteristics in selected cancer sites, 2001–2010.
|
Colorectal |
Breast |
Prostate |
Lung |
|||||
| Total patients | 275 985 |
359 771 |
286 426 |
283 940 |
||||
| Patients age ⩾65 | 73.3% |
44.3% |
77.4% |
74.7% |
||||
| Age group | 18–64 | ⩾65 | 18–64 | ⩾ 65 | 18–64 | ⩾65 | 18–64 | ⩾65 |
| Share female | 41.5% | 46.4% | 100.0% | 100.0% | 0.0% | 0.0% | 43.3% | 42.1% |
| Average age | 55.6 | 77.1 | 52.2 | 76.4 | 59.2 | 75.4 | 57.2 | 76.4 |
| Stages 1–2 | 45.8% | 52.0% | 88.2% | 83.5% | — | — | — | — |
| Share in most deprived quintile | 17.2% | 16.2% | 14.9% | 15.0% | 13.5% | 13.8% | 28.6% | 25.2% |
| 12 month survival | 83.1% | 65.8% | 97.7% | 87.8% | 97.4% | 88.3% | 37.1% | 25.4% |
| Surgery in the first 12 monthsa | 60.7% | 52.2% | 77.6% | 59.0% | 22.0% | 4.3% | 12.6% | 6.9% |
a
Surgery was defined using the following OPCS-4 codes: colorectal (H04, H05, H06, H07, H08, H09, H10, H11 and H33); breast (B27 and B28); prostate (M611, M614, M618 and M619); lung (E391, E398, E399, E441,E461, E541, E542, E543, E544, E545, E548, E549, E552, E554, E559, E574, E578, E595 and T013).